Alnylam Pharmaceuticals, Inc. (FRA:DUL)
Germany flag Germany · Delayed Price · Currency is EUR
340.10
-2.60 (-0.76%)
At close: Jan 9, 2026

Alnylam Pharmaceuticals Market Cap

Alnylam Pharmaceuticals has a market cap or net worth of €45.24 billion as of January 9, 2026. Its market cap has increased by 50.52% in one year.

Market Cap
45.24B
Enterprise Value
45.28B
Revenue
2.74B
Ranking
n/a
PE Ratio
1,218.33
Stock Price
€340.10

Market Cap Chart

Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 94.86M to 45.24B, an increase of 47,589.12%. That is a compound annual growth rate of 32.99%.

History

DateMarket Cap% Change
Jan 9, 202645.24B1.10%
Dec 31, 202544.74B52.63%
Dec 31, 202429.32B34.90%
Dec 29, 202321.73B-20.57%
Dec 30, 202227.36B53.40%
Dec 31, 202117.83B44.47%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition